-
Shaped ABC Coil-Bottlebrush Terpolymer Self-Assembly
2026-09-15
This study shows that digitally shaped bottlebrush blocks can strongly alter phase selection in ABC coil-bottlebrush terpolymers. Although the materials displayed robust microphase separation, shaped architectures suppressed double-gyroid formation and did not produce rapid structural refinement, establishing important constraints for designing large-period network materials.
-
Imatinib Hydrochloride: State-Aware Kinase Assays
2026-09-15
Imatinib hydrochloride is a versatile tool for kinase-driven oncology research. This article develops a state-aware assay framework that connects target inhibition, phosphorylation turnover, and conformational biology without overstating evidence from p38α studies.
-
SB 225002 CXCR2 Assay Workflows
2026-09-14
SB 225002 offers a selective way to separate CXCR2-dependent neutrophil trafficking from the CXCR1-centered IL-8 signaling reported in oral cancer cells. This guide provides practical chemotaxis workflows, receptor-resolution controls, EV-conditioned models, and troubleshooting strategies.
-
MRSA Extracellular Vesicles Drive Oral Cancer via IL-8
2026-09-14
A 2026 study shows that extracellular vesicles from methicillin-resistant Staphylococcus aureus promote oral squamous cell carcinoma proliferation through an IL-8–CXCR1 signaling circuit. By combining vesicle uptake, cargo analysis, pathway inhibition, genetic IL-8 loss, and CXCR1 blockade, the work links antibiotic-resistant bacteria with tumor progression while defining important boundaries for CXCR2-focused chemotaxis studies.
-
PBA-Modified PAD4 Inhibitors: Findings from Compound 5i
2026-09-13
The reference study developed phenylboronic acid-modified PAD4 inhibitors designed to preferentially enter tumor cells while suppressing PAD4-dependent histone H3 citrullination and NET biology in neutrophils. Its lead compound, 5i, reduced primary tumor growth and lung metastasis in mouse models and offers a useful framework for studying tumor-targeted regulation of the PAD4–H3cit–NET axis.
-
GSTA1 Drives Glutathione Depletion in α-Amanitin Toxicity
2026-09-12
The reference study identifies GSTA1 as an unexpected driver of α-amanitin hepatotoxicity: toxin-associated GSTA1 upregulation accelerates glutathione loss, reactive oxygen species accumulation, and hepatocyte injury rather than providing protection. Its combination of multi-omics, target-interaction assays, and genetic silencing offers a mechanistic framework for studying redox-dependent toxic liver injury.
-
HATU Workflows for Selective Inhibitor Synthesis
2026-09-12
HATU converts challenging carboxylic acid coupling steps into practical, monitorable workflows for peptide synthesis chemistry and medicinal chemistry libraries. This guide connects DIPEA-mediated activation with the stereochemically defined inhibitor design and selectivity strategy reported for IRAP and related aminopeptidases.
-
Regorafenib (BAY 73-4506) Research Workflows
2026-09-11
Build translational assays around Regorafenib’s combined effects on receptor tyrosine kinases, angiogenesis, tumor-cell invasion, and melanoma signaling. This workflow connects concentration selection and solvent handling with RRM2–ERK/E2F3 mechanistic validation and tumor-model planning.
-
gamma-Glu-Cys (γ-Glu-Cys) Research Workflow
2026-09-11
gamma-Glu-Cys (γ-Glu-Cys) provides a defined, soluble intermediate for glutathione synthetase enzyme assays and controlled studies of glutathione metabolism, phytochelin formation, and related peptide workflows. It is intended for research use with freshly prepared solutions and should not be used for diagnostic, clinical, or therapeutic applications.
-
NADH Workflows for Mitochondrial Research
2026-09-10
Build more informative redox and respiration experiments with NADH, from paired NADH/NAD⁺ measurements to Seahorse-based mitochondrial profiling. This guide translates liver-injury findings into practical workflows while distinguishing established applications from exploratory uses in diabetic nephropathy research, Leigh syndrome models, and photocatalytic cancer therapy.
-
DiscoveryProbe™ Stem Cell Compound Library Plus
2026-09-10
A scenario-driven guide to using DiscoveryProbe™ Stem Cell Compound Library Plus (SKU L1040P) for stem cell pathway profiling, phenotypic screening, proliferation studies, and cytotoxicity triage. It connects library composition and analytical validation with quantitative high-content screening practices and practical hit-confirmation decisions.
-
EZ Cap EGFP mRNA 5-moUTP: Workflow Guide
2026-09-09
Use EZ Cap EGFP mRNA 5-moUTP as a bright, stability-oriented reporter for optimizing delivery, translation, and cell-state assays. This guide connects Cap1 and 5-moU design with machine-learning-assisted LNP screening, practical controls, and troubleshooting for in vitro and in vivo workflows.
-
Degarelix acetate: Assay Workflows & Optimization
2026-09-09
Build more reproducible GnRH receptor, hormone secretion, and prostate cancer research assays with a workflow that connects receptor antagonism to LH, FSH, and testosterone readouts. Practical dosing, handling, and troubleshooting guidance helps distinguish true pharmacology from formulation, timing, and cell-model artifacts.
-
Sinapine Protects C2C12 Cells from ROS-Induced Death
2026-09-08
The reference study shows that sinapine protects C2C12 myoblasts from tert-butyl hydroperoxide-induced oxidative injury by reducing ROS accumulation, MAPK activation, and autophagy-associated changes. Its inhibitor-based experiments connect MAPK signaling with cell death and LC3B-II accumulation, providing a mechanistic framework for studying oxidative stress in skeletal muscle models.
-
Caffeine Workflows for Cancer and Metabolic Research
2026-09-08
Caffeine supports reproducible concentration–response studies, VPA combination experiments, and metabolic phenotyping in diet-induced obesity mouse models. This guide pairs practical assay conditions with evidence boundaries and uses a recent ALDH2 activator study to improve controls without misattributing its cardiovascular findings to caffeine.